News

BioWorld MedTech
bioworld.com > articles > 729449-vertex-filing-bla-for-best-in-class-igan-drug-on-rainier-win

Vertex filing BLA for ‘best-in-class’ IgAN drug on Rainier win

2+ hour, 30+ min ago  (25+ words) Vertex filing BLA for "best-in-class" IgAN drug on Rainier win'BioWorld MedTech Vertex filing BLA for "best-in-class" IgAN drug on Rainier win...

BioWorld MedTech
bioworld.com > articles > 729520-gipr-antagonists-reported-in-pfizer-patent

GIPR antagonists reported in Pfizer patent

9+ hour, 8+ min ago  (13+ words) GIPR antagonists reported in Pfizer patent'BioWorld MedTech GIPR antagonists reported in Pfizer patent...

BioWorld MedTech
bioworld.com > articles > 729519-shionogi-patents-new-agents-for-hiv-1-infection

Shionogi patents new agents for HIV-1 infection

9+ hour, 8+ min ago  (17+ words) Shionogi patents new agents for HIV-1 infection'BioWorld MedTech Shionogi patents new agents for HIV-1 infection...

BioWorld MedTech
bioworld.com > articles > 729583-kyowa-kirin-discontinues-rocatinlimab-trials-due-to-safety-issues

Kyowa Kirin discontinues rocatinlimab trials due to safety issues

7+ hour, 56+ min ago  (19+ words) Kyowa Kirin discontinues rocatinlimab trials due to safety issues'BioWorld MedTech Kyowa Kirin discontinues rocatinlimab trials due to safety issues...

BioWorld MedTech
bioworld.com > articles > 729455-telix-advances-psma-radiotherapy-challenger-to-pluvicto

Telix advances PSMA radiotherapy challenger to Pluvicto

7+ hour, 56+ min ago  (188+ words) Telix advances PSMA radiotherapy challenger to Pluvicto'BioWorld MedTech Telix advances PSMA radiotherapy challenger to Pluvicto These are cookies necessary for the services to function and are always active. They are usually only set in response to actions made by the…...

BioWorld MedTech
bioworld.com > articles > 729586-japan-approves-first-ipsc-therapy-for-parkinsons-disease

Japan approves first iPSC therapy for Parkinson’s disease

7+ hour, 56+ min ago  (19+ words) Japan approves first iPSC therapy for Parkinson's disease'BioWorld MedTech Japan approves first iPSC therapy for Parkinson's disease...

BioWorld MedTech
bioworld.com > articles > 729509-c-further-unveils-pediatric-cancer-programs

C-Further unveils pediatric cancer programs

10+ hour, 56+ min ago  (13+ words) C-Further unveils pediatric cancer programs'BioWorld MedTech C-Further unveils pediatric cancer programs...

BioWorld MedTech
bioworld.com > articles > 729585-china-approves-first-noninvasive-therapy-for-cervical-precancer

China approves first noninvasive therapy for cervical precancer

7+ hour, 56+ min ago  (17+ words) China approves first noninvasive therapy for cervical precancer'BioWorld MedTech China approves first noninvasive therapy for cervical precancer...

BioWorld MedTech
bioworld.com > articles > 729507-three-pediatric-brain-cancer-types-share-a-pineal-gland-origin

Three pediatric brain cancer types share a pineal gland origin

9+ hour, 10+ min ago  (78+ words) Similarities among three pediatric brain tumors that arise in different structures of the CNS " pineoblastoma, retinoblastoma and Group 3 medulloblastoma " have been linked to their shared origin during pineal gland development. Scientists at St. Jude Children's Research Hospital have identified the…...

BioWorld MedTech
bioworld.com > articles > 729437-ipsen-pulls-tazverik-from-us-market-on-secondary-malignancies

Ipsen pulls Tazverik from US market on secondary malignancies

1+ day, 7+ hour ago  (19+ words) Ipsen pulls Tazverik from US market on secondary malignancies'BioWorld MedTech Ipsen pulls Tazverik from US market on secondary malignancies...